During the first half of 2023, Brain+ has successfully built upon its initial commercial success with a Danish municipality by securing an e...
Brain+ A/S published its Semi-Annual Report for 2023 on August 31 and are showing progress.
In 2022, Brain+ had a successful commercial introduction of its CST-Therapist Companion dementia product in Denmark and secured the first sa...
Brain+ A/S published its Annual Report for 2022 on April 28.
On March 29, 2023, Brain+ announced that the Company intends to carry out a preferential Rights Issue of shares and warrants of series TO 2 ...
On March 20, 2023, Brain+ A/S (“Brain+” or “the Company”) announced that the Danish municipality Herning Municipality has decided to expand ...
On January 11, 2023, Brain+ released the findings of a study conducted by Nottingham University as part of the Alzheimer’s Detect & Prevent ...
On the 14h of December 2022, Brain+ A/S (“Brain+” or the ”Company”) announced that the Company has successfully completed the implementation...
On the 19th of October 2022, Brain+ A/S (“Brain+” or the "Company”) announced that the Company has been selected and featured as a 2022 TMC-...
Analyst Group has entered into an agreement with Brain+ on commissioned research, including Equity Research Reports with recurring updates a...
